Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1155607.RAUiCBzxGbzXj9LqaQxCOTuM3wYTjqgm18K-khOS-mvXc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1155607.RAUiCBzxGbzXj9LqaQxCOTuM3wYTjqgm18K-khOS-mvXc130_assertion type Assertion NP1155607.RAUiCBzxGbzXj9LqaQxCOTuM3wYTjqgm18K-khOS-mvXc130_head.
- NP1155607.RAUiCBzxGbzXj9LqaQxCOTuM3wYTjqgm18K-khOS-mvXc130_assertion description "[Target genes of miR-122, including cyclin G1, a disintegrin and metalloprotease (ADAM)10, serum response factor, insulin-like growth factor-1 receptor, ADAM17, transcription factor CUTL1, the embryonic isoform of pyruvate kinase (Pkm2), Wnt1, pituitary tumor-transforming gene 1 binding factor, Cut-like homeobox 1, and c-myc, are involved in hepatocarcinogenesis, epithelial mesenchymal transition, and angiogenesis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1155607.RAUiCBzxGbzXj9LqaQxCOTuM3wYTjqgm18K-khOS-mvXc130_provenance.
- NP1155607.RAUiCBzxGbzXj9LqaQxCOTuM3wYTjqgm18K-khOS-mvXc130_assertion evidence source_evidence_literature NP1155607.RAUiCBzxGbzXj9LqaQxCOTuM3wYTjqgm18K-khOS-mvXc130_provenance.
- NP1155607.RAUiCBzxGbzXj9LqaQxCOTuM3wYTjqgm18K-khOS-mvXc130_assertion SIO_000772 24531873 NP1155607.RAUiCBzxGbzXj9LqaQxCOTuM3wYTjqgm18K-khOS-mvXc130_provenance.
- NP1155607.RAUiCBzxGbzXj9LqaQxCOTuM3wYTjqgm18K-khOS-mvXc130_assertion wasDerivedFrom befree-2016 NP1155607.RAUiCBzxGbzXj9LqaQxCOTuM3wYTjqgm18K-khOS-mvXc130_provenance.
- NP1155607.RAUiCBzxGbzXj9LqaQxCOTuM3wYTjqgm18K-khOS-mvXc130_assertion wasGeneratedBy ECO_0000203 NP1155607.RAUiCBzxGbzXj9LqaQxCOTuM3wYTjqgm18K-khOS-mvXc130_provenance.